Efficacy of elacytarabine as second-line therapy in patients with acute myeloid leukaemia
Phase of Trial: Phase II
Latest Information Update: 29 Jul 2013
At a glance
- Drugs Elacytarabine (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- Sponsors Aqualis
- 29 Jul 2013 Status changed from recruiting to completed.
- 07 Dec 2009 Results were presented at the 51st American Society of Hematology (ASH) Annual Meeting, according to a Clavis media release.
- 04 Dec 2009 Results will be presented at the 51st Annual Meeting of the American Society of Hematology on 5 Dec 2009, according to a Clavis Pharma media release.